 Presentation on Thursday, January 26th, 2023 at 1:30 PM EST TARRYTOWN, NY, Jan. 20, 2023 GLOBE NEWSWIRE via NewMediaWire PaxMedica, Inc. Nasdaq: PXMD, a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies APT for the treatment of disorders with intractable neurologic symptoms, today announced that it will be presenting virtually at... The post PaxMedica to Present at the Jan 26th Virtual Investor Summit Microcap Event appeared fi... 